Silvia de Sanjosé mainly investigates Cervical cancer, Gynecology, Internal medicine, Epidemiology and Odds ratio. Cervical cancer is a subfield of Cancer that she investigates. The Gynecology study combines topics in areas such as Cervix, Mass screening, Confidence interval, Cytology and Obstetrics.
Her work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Oncology. Within one scientific family, Silvia de Sanjosé focuses on topics pertaining to Pathology under Oncology, and may sometimes address concerns connected to Larynx. Her study in Odds ratio is interdisciplinary in nature, drawing from both Immunology, Lymphoma, Case-control study and Risk factor.
Internal medicine, Cervical cancer, Gynecology, Immunology and Cancer are her primary areas of study. Her Internal medicine research is multidisciplinary, relying on both Oncology, Genotype and Pathology. Her study in HPV infection and HPV vaccines are all subfields of Cervical cancer.
Silvia de Sanjosé interconnects Incidence, Human papillomavirus, Papillomaviridae, Obstetrics and Cervical intraepithelial neoplasia in the investigation of issues within Gynecology. Her research on Cancer frequently connects to adjacent areas such as Disease. Her research investigates the connection between Odds ratio and topics such as Epidemiology that intersect with issues in Environmental health.
Her primary areas of investigation include Internal medicine, Cervical cancer, Oncology, Cancer and Logistic regression. The concepts of her Cervical cancer study are interwoven with issues in Gynecology, Triage and Vaccination. Silvia de Sanjosé has researched Gynecology in several fields, including Vulvar cancer and Human papillomavirus.
Her work focuses on many connections between Oncology and other disciplines, such as Etiology, that overlap with her field of interest in Hpv types. Silvia de Sanjosé combines subjects such as Meta-analysis and Incidence with her study of Cancer. Her work in Odds ratio addresses subjects such as Immunology, which are connected to disciplines such as Genome-wide association study.
Silvia de Sanjosé spends much of her time researching Internal medicine, Cervical cancer, Cancer, Pathology and Oncology. In general Internal medicine study, her work on Case-control study, Odds ratio, Confounding and Risk factor often relates to the realm of CagA, thereby connecting several areas of interest. She is studying HPV vaccines, which is a component of Cervical cancer.
Her Cancer research includes elements of Gynecology, Disease and Vaccination. Silvia de Sanjosé has included themes like Papillomaviridae and Human Papillomavirus DNA Test in her Pathology study. Her research in Oncology focuses on subjects like Single-nucleotide polymorphism, which are connected to Bioinformatics, Systemic lupus erythematosus and Diffuse large B-cell lymphoma.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
Nubia Muñoz;F. Xavier Bosch;Silvia de Sanjosé;Rolando Herrero.
The New England Journal of Medicine (2003)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose;Wim G.V. Quint;Laia Alemany;Daan T. Geraets.
Lancet Oncology (2010)
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.
Silvia de Sanjosé;Mireia Diaz;Xavier Castellsagué;Gary Clifford.
Lancet Infectious Diseases (2007)
International network of cancer genome projects
Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
(2010)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente;Magda Pinyol;Víctor Quesada;Laura Conde.
Nature (2011)
Against which human papillomavirus types shall we vaccinate and screen? The international perspective.
Nubia Muñoz;F. Xavier Bosch;Xavier Castellsagué;Mireia Díaz.
International Journal of Cancer (2004)
Cervical Human Papillomavirus Prevalence in 5 Continents: Meta-Analysis of 1 Million Women with Normal Cytological Findings
Laia Bruni;Mireia Diaz;Mireia Castellsagué;Elena Ferrer.
The Journal of Infectious Diseases (2010)
Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality.
F Xavier Bosch;Silvia de Sanjosé.
Journal of The National Cancer Institute Monographs (2003)
Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
F. Xavier Bosch;Ann N. Burchell;Mark Schiffman;Anna R. Giuliano.
Vaccine (2008)
Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners
Xavier Castellsagué;F. Xavier Bosch;Nubia Muñoz;Chris J.L.M. Meijer.
The New England Journal of Medicine (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Open University of Catalonia
International Agency For Research On Cancer
Masaryk University
International Agency For Research On Cancer
Stony Brook Medicine
University of Barcelona
Pompeu Fabra University
Mayo Clinic
Erasmus University Rotterdam
University of British Columbia
Stanford University
Bielefeld University
GlobalFoundries (United States)
Brookhaven National Laboratory
University of California, Davis
Lawrence Berkeley National Laboratory
Cold Spring Harbor Laboratory
Karlsruhe Institute of Technology
University of Bari Aldo Moro
Yale University
University of Delaware
Vita-Salute San Raffaele University
University of Florida
University of Toronto
University of Exeter
University at Albany, State University of New York